Drugs / P005672-HCl
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01628549 | Jun → Nov 2012 | acne | Almirall, S.A. | Completed | Mixed |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P005672-HCl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01628549 ↗ |
| Modality | Small molecule | “Novel Tetracycline” NCT01628549 ↗ |
| Route | Oral | “P005672-HCl administered as an oral capsule(s) once daily” NCT01628549 ↗ |